US Patent 11944658 Methods of heat inactivation of adenovirus
Patent 11944658 was granted and assigned to Ultragenyx Pharmaceutical on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+548 characters)
US Patent 11944658 Methods of heat inactivation of adenovirus
Article
Patent abstract
The present disclosure generally relates to methods of protecting the genomic integrity and/or biological activity of AAV viral particles in a sample containing both AAV particles and helper virus particles during heat inactivation. The methods include heating, to a temperature greater than or equal to 45′C, a sample containing helper virus particles, AAV particles, and a buffer. The buffer includes a concentration of 10 mM or greater kosmotropic salts and/or a concentration of 10 mM or greater of divalent or trivalent cations.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christopher J. Morrison0
James D. Maratt0
Date of Patent
April 2, 2024
0Patent Application Number
172387430
Date Filed
April 23, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11944658 Methods of heat inactivation of adenovirus
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
